Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor
Disclaimer: All resources on this site are collected from the internet. If any content infringes on your rights, please contact us and we will remove it within 24 hours.
Like 
Dislike